Lapatinib (GW572016)
Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM in cell-free assays, respectively. Lapatinib induces ferroptosis and autophagic cell death.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
J Chromatogr B Analyt Technol Biomed Life Sci.2019, 1113:1-13
Oxid Med Cell Longev.2021, 2021:4883398.
J.of Traditional&Complementary Med.2022, 10.1016:j.jtcme.
Biomimetics (Basel).2022, 7(4):154.
Crystals2020, 10(3), 206.
Toxicol Res.2019, 35(4):371-387
Proc Biol Sci.2024, 291(2015):20232578.
Fundam. Toxicol. Sci.2024, 11(4):197-204
J Biochem Mol Toxicol.2017, 31(9)
The Japan Society for Analytical Chemistry2018, 67(4):201-206
Related and Featured Products
Mol Cancer Ther,2001 Dec;1(2):85-94.
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.[Pubmed:
12467226]
Cell lines:HFF, MCF-7, T47D, A-431, HN5, BT474, N87, CaLu-3, HB4a, and HB4a c5.2 cells
Concentrations: Dissolved in DMSO, final concentrations ~100 μM
Incubation Time: 12.3, 24.5 and 49 mg/kg
Method:
Cells are exposed to various concentrations of Lapatinib for 72 hours. Relative cell number is estimated using methylene blue staining. The absorbance at 620 nm is read in a Spectra microplate reader. Cell death and cell cycle analysis are assessed by propidium iodide staining and antibody detection of incorporated BrdUrd and staining with propidium iodide.
Mol Cancer Ther,2001 Dec;1(2):85-94.
The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.[Pubmed:
12467226]
Animal Models: CD-1 nude female mice implanted s.c. with HN5 cells, and C.B-17 SCID female mice implanted s.c. with BT474 cells
Dosages: ~100 mg/kg
Administration: Orally twice daily
